Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.6 HKD | +3.35% | +10.54% | +5.62% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.62% | 8.32B | |
+14.94% | 69.91B | |
+2.12% | 25.14B | |
+6.10% | 8.07B | |
-21.85% | 7.97B | |
+0.73% | 4.56B | |
+17.40% | 4.31B | |
-0.14% | 3.99B | |
-2.34% | 3.87B | |
+21.03% | 3.63B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm : China National Accord Medicines' 2020 Net Profit Rises Nearly 11%